PMID: 7683954

Nunes V, Chillon M, Dork T, Tummler B, Casals T, Estivill X
A new missense mutation (E92K) in the first transmembrane domain of the CFTR gene causes a benign cystic fibrosis phenotype.
Hum Mol Genet. 1993 Jan;2(1):79-80., [PubMed]
Sentences
No. Mutations Sentence Comment
1 ABCC7 p.Glu92Lys
X
ABCC7 p.Glu92Lys 7683954:1:31
status: NEW
view ABCC7 p.Glu92Lys details
79-80 A new missense mutation (E92K) in the first transmembrane domain of the CFTR gene causes a benign cystic fibrosis phenotype V.Nunes, M.Chill6n, T.Dfirk1 , B.Tummler1 , T.Casals and X.Estivill* Molecular Genetics Department, Cancer Research Institute (IRO), Hospital Duran i Reynals, Campus Bellvitge, Av. Castelldefels Km 2.7, L'Hospitalet de LJobregat, E-08907 Barcelona, Spain and 1 Abteilung Biophysikalische Chemie, OE 4350, Medizinische Hochschule Hannover, D-30XX) Hannover 61, Germany Received October 22, 1992; Revised and Accepted October 30, 1992 The Cystic Fibrosis Transmembrane Conductance (CFTR) gene contains 27 exons spread over approximately 250 kb of genomic DNA (1,2,3). Login to comment
3 ABCC7 p.Glu92Lys
X
ABCC7 p.Glu92Lys 7683954:3:64
status: NEW
view ABCC7 p.Glu92Lys details
We describe a new missense mutation in exon 4 of the CFTR gene, E92K, discovered by single strand conformation polymorphism (SSCP) (5) analysis, in the screening of Spanish CF families. Login to comment
4 ABCC7 p.Glu92Lys
X
ABCC7 p.Glu92Lys 7683954:4:40
status: NEW
view ABCC7 p.Glu92Lys details
ABCC7 p.Glu92Lys
X
ABCC7 p.Glu92Lys 7683954:4:69
status: NEW
view ABCC7 p.Glu92Lys details
The clinical features of a heterozygous E92K/unknown mutation and an E92K homozygous patient are described. Login to comment
8 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 7683954:8:171
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Asp110His
X
ABCC7 p.Asp110His 7683954:8:164
status: NEW
view ABCC7 p.Asp110His details
SSCP conditions for exon 4 of the CFTR gene, which allow discrimination of mutant and wild type alleles, were developed for several control mutations at this exon: D110H, R117H, 556delA and 621+ 1G-T (8, 9). Login to comment
10 ABCC7 p.Glu92Lys
X
ABCC7 p.Glu92Lys 7683954:10:102
status: NEW
view ABCC7 p.Glu92Lys details
ABCC7 p.Glu92Lys
X
ABCC7 p.Glu92Lys 7683954:10:158
status: NEW
view ABCC7 p.Glu92Lys details
Analysis of the abnormal band showed that it contained a G to A transition (G-A at 406) that replaces glutamic acid by lysine at codon 92 of exon 4 (mutation E92K) (Figure IB). Login to comment
11 ABCC7 p.Glu92Lys
X
ABCC7 p.Glu92Lys 7683954:11:0
status: NEW
view ABCC7 p.Glu92Lys details
E92K can easily be detected by restriction enzyme digestion, as the mutation destroys an EcoNl site. Login to comment
15 ABCC7 p.Glu92Lys
X
ABCC7 p.Glu92Lys 7683954:15:79
status: NEW
view ABCC7 p.Glu92Lys details
The subsequent screening of German patients for mutations in exon 4, including E92K, led to the identification of a homozygous patient for this mutation. Login to comment
17 ABCC7 p.Glu92Lys
X
ABCC7 p.Glu92Lys 7683954:17:0
status: NEW
view ABCC7 p.Glu92Lys details
E92K was not detected in further 150 non-AF508 German CF chromosomes. Login to comment
18 ABCC7 p.Glu92Lys
X
ABCC7 p.Glu92Lys 7683954:18:63
status: NEW
view ABCC7 p.Glu92Lys details
Clinical characteristics of the two patients carrying mutation E92K are shown in Table 1. Login to comment
19 ABCC7 p.Glu92Lys
X
ABCC7 p.Glu92Lys 7683954:19:166
status: NEW
view ABCC7 p.Glu92Lys details
The two affected boys are of similar 10 11 12 13 14 15 16 17 18 19 B Normal Heterozygous 1 ' • * A 1 1 \ 1 N A A • Cut fragment L A A A • EXON 4 E92K Figure 1. Login to comment
20 ABCC7 p.Glu92Lys
X
ABCC7 p.Glu92Lys 7683954:20:29
status: NEW
view ABCC7 p.Glu92Lys details
Characterization of mutation E92K. Login to comment
26 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 7683954:26:19
status: NEW
view ABCC7 p.Arg117His details
Lanes 1 and 2 were R117H and621 + l G - T mutations used as controls. Login to comment
27 ABCC7 p.Glu92Lys
X
ABCC7 p.Glu92Lys 7683954:27:48
status: NEW
view ABCC7 p.Glu92Lys details
The abnormal fragment corresponding to mutation E92K is in lane 18. Login to comment
32 ABCC7 p.Glu92Lys
X
ABCC7 p.Glu92Lys 7683954:32:36
status: NEW
view ABCC7 p.Glu92Lys details
Clinical and laboratory features of E92K individuals Genotype Current age Age at diagnosis Sex Sweat chloride mEq./l. Login to comment
33 ABCC7 p.Glu92Lys
X
ABCC7 p.Glu92Lys 7683954:33:245
status: NEW
view ABCC7 p.Glu92Lys details
Meconium ileus Dehydration Height-cm (%ile) Weight-Kg (%ile) Chrispin - Norman* Lung colonization with bacterial pathogens Pancreatic insufficiency Shwachman - Kulczyclrib FEV1-% predicted FVC-% predicted Other clinical features Patient Spanish E92K/unknown 9 y. Login to comment
34 ABCC7 p.Glu92Lys
X
ABCC7 p.Glu92Lys 7683954:34:73
status: NEW
view ABCC7 p.Glu92Lys details
ABCC7 p.Glu92Lys
X
ABCC7 p.Glu92Lys 7683954:34:78
status: NEW
view ABCC7 p.Glu92Lys details
6 m. 9 months male 92 no no 135(75) 27 (45) 1 no no 100 98 88 no Turkish E92K/E92K 8 y. Login to comment
44 ABCC7 p.Glu92Lys
X
ABCC7 p.Glu92Lys 7683954:44:0
status: NEW
view ABCC7 p.Glu92Lys details
E92K is a missense mutation in the first nucleotide of exon 4, occurring in the first transmembrane domain of the CFTR gene. Login to comment
48 ABCC7 p.Glu92Lys
X
ABCC7 p.Glu92Lys 7683954:48:8
status: NEW
view ABCC7 p.Glu92Lys details
As both E92K chromosomes are associated with the same 2-2-1-1-1 haplotype for MetH/MspI, XV-2c/TaqI, KM.19/PstI, MP6d-9/MspI, J3.11/Mspl, a common origin of this mutation could be postulated, which should be further confirmed using intragenic markers (12). Login to comment
49 ABCC7 p.Glu92Lys
X
ABCC7 p.Glu92Lys 7683954:49:40
status: NEW
view ABCC7 p.Glu92Lys details
It might be useful to consider mutation E92K when analysing CF chromosomes from Northern African and Anatolian or Iranian/Armenian CF chromosomes. Login to comment
50 ABCC7 p.Glu92Lys
X
ABCC7 p.Glu92Lys 7683954:50:4
status: NEW
view ABCC7 p.Glu92Lys details
The E92K homozygous patient has allowed us to assess clinical features for this mutation alone, establishing a good correlation between the mutation and the benign phenotype produced. Login to comment
51 ABCC7 p.Glu92Lys
X
ABCC7 p.Glu92Lys 7683954:51:10
status: NEW
view ABCC7 p.Glu92Lys details
The other E92K patient, who has an as yet uncharacterized mutation in the other CF chromosome, also has a very moderate presentation. Login to comment
52 ABCC7 p.Glu92Lys
X
ABCC7 p.Glu92Lys 7683954:52:55
status: NEW
view ABCC7 p.Glu92Lys details
Therefore, clinical data in both patients suggest that E92K is a very benign CF mutation, accompanied by the absence of classical CF symptoms of pulmonary and gastrointestinal disease. Login to comment